Quanterix Corp QTRX
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if QTRX is a good fit for your portfolio.
News
-
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
-
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
-
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
-
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
-
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
-
Quanterix to Present at Cowen’s 44th Annual Health Care Conference
-
Quanterix Fourth Quarter Earnings and Full Year 2023 Financial Results Conference Call
Trading Information
- Previous Close Price
- $16.10
- Day Range
- $15.43–16.10
- 52-Week Range
- $11.39–29.70
- Bid/Ask
- $16.04 / $16.07
- Market Cap
- $613.48 Mil
- Volume/Avg
- 386,796 / 371,006
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.98
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory, Homebrew – Custom Assay Development, and Uman NF-Light.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 141
- Website
- https://www.quanterix.com
Comparables
Valuation
|
Metric
|
QTRX
|
QSI
|
RVTY
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 22.08 |
Price/Book Value | 1.76 | 0.87 | 1.61 |
Price/Sales | 4.98 | 218.10 | 4.66 |
Price/Cash Flow | — | — | 19.11 |
Price/Earnings
QTRX
QSI
RVTY
Financial Strength
|
Metric
|
QTRX
|
QSI
|
RVTY
|
|---|---|---|---|
Quick Ratio | 9.02 | 22.23 | 1.54 |
Current Ratio | 9.84 | 22.94 | 2.07 |
Interest Coverage | — | — | 2.12 |
Quick Ratio
QTRX
QSI
RVTY
Profitability
|
Metric
|
QTRX
|
QSI
|
RVTY
|
|---|---|---|---|
Return on Assets (Normalized) | −3.88% | −27.02% | 1.95% |
Return on Equity (Normalized) | −4.69% | −29.37% | 3.52% |
Return on Invested Capital (Normalized) | −7.33% | −30.81% | 2.47% |
Return on Assets
QTRX
QSI
RVTY
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Gzqqswx | Dqfcnvy | $185.5 Bil | |
SYK
| Stryker Corp | Wclkrnbr | Ghb | $128.2 Bil | |
MDT
| Medtronic PLC | Rvmkmvrvc | Mybsnh | $106.7 Bil | |
BSX
| Boston Scientific Corp | Hcddbrlx | Ryyvf | $99.0 Bil | |
DXCM
| DexCom Inc | Hqvmgzjrvq | Kmxl | $53.1 Bil | |
EW
| Edwards Lifesciences Corp | Njjknlgj | Dbcxn | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Vvdnzyng | Gfsc | $24.9 Bil | |
ALGN
| Align Technology Inc | Nqtqtnsj | Xygfcx | $23.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Ygrczynkn | Mbkzktg | $18.9 Bil | |
PODD
| Insulet Corp | Vzrdylvl | Vpxqvf | $11.7 Bil |